Table 5.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2001 to 2005

Recipients with Kidney Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 12,012 100.0% 61,575 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 248 2.1% 1,055 1.7%
OKT3 21 0.2% 343 0.6%
Thymoglobulin 5,237 43.6% 17,258 28.0%
Zenapax 874 7.3% 8,327 13.5%
Simulect 1,399 11.6% 14,485 23.5%
Campath 1,682 14.0% 1,270 2.1%
Rituximab 3 0.0% 20 0.0%
No Induction Drug Reported 2,902 24.2% 20,800 33.8%


Source: OPTN/SRTR Data as of May 1, 2006.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.